BIOTECH in Mathrubhumi NEWS 'Nalla Vartha' with DR.A Sajidas

| August 26, 2016

article image
www.biotech-india.orgBIOTECH , a synonym for ENVIRONMENT, ENERGY, POWER, ECO-FRIENDLINESS, HYGIENE AND HEALTH, has been established as a Non-Governmental Organization (NGO), in 1994, even though its activities originated long before during the early eighties. BIOTECH has been registered under the Charitable Societies Registration Act, with its head quarters functioning at Thiruvananthapuram. BIOTECH is engaged in the implementation, promotion, popularization and research in Bio-Waste Management, Non-conventional Energy and Energy Conservation Programmes.

Spotlight

Circulomics Inc

Circulomics is a Maryland biotechnology company that spun out of a $14M Cancer Nanomedicine Center at Johns Hopkins to commercialize micro- and nanotechnology enabled tools for biomarker analysis and cancer diagnostics. These tools include Nanobind DNA/RNA Extraction Technology, Ligo-miR Multiplexed microRNA Assay, and PicoSep Single Molecule DNA Sizing Platform.

OTHER ARTICLES

Defense biotech research looks to eliminate bacteria causing traveler’s diarrhea, reduce jet lag duration

Article | April 9, 2020

World traveler‘s will rejoice at the idea of a seemingly magical device that would guarantee they never suffer from the all-too-familiar stomach issues that come from traveling internationally while reducing jet lag at the same time. But it’s not just privileged globetrotters that would benefit from a device that eliminates the bacteria associated with the so-called Montezuma’s Revenge. In 2016, more than 230,000 children around the world died from some of the same types of bacteria as those that cause traveler’s diarrhea, and the bacteria mainly come from unsafe “drinking water, poor sanitation and malnutrition,” according to Oxford University’s Our World In Data portal. On Monday, DARPA announced it was researching an “implantable or ingestible bioelectronic carrier” that would eliminate the five major bacteria associated with traveler’s diarrhea.

Read More

Cell Out? Lysate-Based Expression an Option for Personalized Meds

Article | February 18, 2020

Cell-free expression (CFE) is the practice of making a protein without using a living cell. In contrast with cell line-based methods, production is achieved using a fluid containing biological components extracted from a cell, i.e., a lysate. CFE offers potential advantages for biopharma according to Philip Probert, PhD, a senior scientist at the Centre for Process Innovation in the U.K.

Read More

2 Small-Cap Biotech Stocks You Haven't Heard of, But Should Know About

Article | April 17, 2020

With everything that's going on with the COVID-19 pandemic, many healthcare companies have grabbed plenty of spotlight during these challenging times. At the same time, a number of otherwise promising businesses have slipped under the radar. That's especially true for small-cap biotech stocks that aren't actively involved in developing tests, vaccines or treatments for COVID-19. Vaccine developers, protective equipment producers, and healthcare service providers are all attracting plenty of attention during this pandemic, but there are just as many promising biotech stocks that aren't involved in these areas. Here are two such companies that you might have missed, but they deserve a spot on your watch list.

Read More

Top 10 biotech IPOs in 2019

Article | February 24, 2020

The big question at the start of 2019 was whether the IPO window would stay open for biotech companies, particularly those seeking to pull off ever-larger IPOs at increasingly earlier stages of development. The short answer is yes—kind of. Here’s the long answer: In the words of Renaissance Capital, the IPO market had “a mostly good year.” The total number of deals fell to 159 from 192 the year before, but technology and healthcare companies were standout performers. The latter—which include biotech, medtech and diagnostics companies—led the pack, making up 43% of all IPOs in 2019. By Renaissance’s count, seven companies went public at valuations exceeding $1 billion, up from five the year before

Read More

Spotlight

Circulomics Inc

Circulomics is a Maryland biotechnology company that spun out of a $14M Cancer Nanomedicine Center at Johns Hopkins to commercialize micro- and nanotechnology enabled tools for biomarker analysis and cancer diagnostics. These tools include Nanobind DNA/RNA Extraction Technology, Ligo-miR Multiplexed microRNA Assay, and PicoSep Single Molecule DNA Sizing Platform.

Events